Lv5
1044 积分 2026-07-24 加入
EP.06.16 Immunophenotyping of the Molecular Subtypes of Small Cell Lung Cancer and Its Correlation With Prognostic and Therapeutic Implications
1个月前
已关闭
MA11.01 Phase 1 Study of DLL3-Targeted CAR-T Cells Armored With dnTGFBR2 in Small-Cell Lung and Large-Cell Neuroendocrine Cancers
1个月前
已关闭
Emerging therapies and translational advances in small cell lung cancer: Overcoming resistance
1个月前
已完结
Clinical utility of immunohistochemical subtyping in patients with small cell lung cancer
1个月前
已完结
Antiangiogenic therapy enhances CAR-T cell efficacy in solid tumors: Insights from a hybrid multiscale model
1个月前
已完结
Advances in CAR ‐T therapy for small cell lung cancer
1个月前
已完结
Class I HDAC inhibitors enhance antitumor efficacy and persistence of CAR-T cells by activation of the Wnt pathway
1个月前
已完结
Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer
1个月前
已完结
Brief Report: Low Delta-Like Ligand 3 Expression and T-Cell Exhaustion Drive Resistance to Tarlatamab Combined With Anti-Programmed Cell Death Protein 1 in SCLC
1个月前
已完结
Immunotherapy for extensive-stage small cell lung cancer: current status, challenges and future strategies
1个月前
已完结
皖公网安备34019202002308
